January 21st, 2021

Manager Magazin // How East Westphalia-Lippe became a hotspot for the digital scene

For a long time, the region stood for big middle-class companies and old money: rich, but a little sleepy. Now the province is breaking into the digital modern age.
Torsten Bendlin (51), a single father, business administrator, 17 years with kitchen manufacturer Nolte in Löhne, most recently as head of corporate purchasing, first heard the word pitch six years ago when he was doing his international MBA [...]
[Translated with www.DeepL.com/Translator]

Read more

January 18th, 2021

Press Release // AI startup Semalytix receives € 2 million from NRW.BANK.Venture Fund

As part of an extended Series A financing round, NRW.BANK is investing in Semalytix with its venture fund. The Bielefeld-based startup has developed the artificial intelligence-based platform “Pharos” for the systematic research of patient needs. The aim is to improve future generations of drugs by recording patients’ treatment experience and uncovering any unknown side effects. The company plans to expand its software, improve performance, and further strengthen its market position with the investment. [...]

Read more

January 5th, 2021

Das kommt aus Bielefeld.de // The ear to the net

Artificial intelligence is their métier. "We focus on the pharmaceutical business with the algorithms and tools we develop," says Janik Jaskolski, CEO of Semalytix, a Bielefeld-based startup founded in 2015 and created as a spin-off of the Semantic Computing research group. The goal is to improve treatment methods for people by incorporating the patient perspective or their insights.
[...]
[Translated with www.DeepL.com/Translator]

Read more

November 24th, 2020

October 30th, 2020

Handelsblatt // Focus wanted

Read more

August 31st, 2020

TechCruch // Semalytix picks up €4.3M to build the world’s largest patient experience data set

Semalytix, a Bielefeld, Germany-based startup that offers pharmaceutical companies an AI-powered data tool to better understand real-world patient experiences, has raised €4.3 million in Series A funding [...]

Read more

May 24th, 2019

StartupValley Magazine // Have the courage and self-confidence to think big 

Semalytix: Machine Reading in combination with Data Story Telling. Please introduce yourself and the startup Semalytix to our readers! My name is Janik Jaskolski, I am co-founder and managing director of Semalytix. Simply put, we teach computers to read and explain these read digital texts. Our main focus is to make medical content understandable. We transform [...][Translated with www.DeepL.com/Translator]

Read more

May 6th, 2019

January 21rst, 2019

Press Release // Bielefeld-based start-up Semalytix participates in EU research project

Prêt-à-LLOD: Ready-to-use Multilingual Linked Language Data for Knowledge Services across Sectors - this is the name under which a research project was launched at the beginning of 2019 for which the European Commission is providing €3 million under the Horizon 2020 funding line […]

Read more

November 26th, 2018

Forbes // Meet The 100 Most Innovative Startups Of Germany In 2018 (Forbes)

The Hundertis a Berlin-based startup project and print magazine featuring outstanding companies and their founders since 2013. Every issue puts 100 amazing startups in the spotlight and tells their stories […]

Read more

November 26th, 2018

The Hundert // Dark Data Understanding 

Semalytix is a Spin-Off out of Bielefeld University. They move cutting edge research into the business intelligence and competitive intelligence markets to help teams maximize their competitive edge and return on investment. Highlight of the year: Closing Seed-Funding round to accelerate product development and goto-market […]

Read more

November 17th, 2018

Wirtschaftswoche Economy 4.0 // Semalytix brings light into the global pharmaceutical industry 

Mr. Jaskolski, what added value does Semalytix offer the pharmaceutical industry? We are working on using Artificial Intelligence (AI) to explain the global conversation around the core values of the pharmaceutical industry. Our technology is able to develop a human-like understanding of text and thus make complex relationships in large amounts of unstructured data accessible to the user. Our AI-as-a-Service platform combines information from the following sources […]
[Translated with www.DeepL.com/Translator]

Read more